Tempus AI, Inc. (NASDAQ:TEM) CFO James William Rogers Sells 1,468 Shares

by · The Markets Daily

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) CFO James William Rogers sold 1,468 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $40.23, for a total value of $59,057.64. Following the transaction, the chief financial officer now owns 229,812 shares in the company, valued at $9,245,336.76. The trade was a 0.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

James William Rogers also recently made the following trade(s):

  • On Wednesday, December 11th, James William Rogers sold 83,025 shares of Tempus AI stock. The stock was sold at an average price of $42.30, for a total value of $3,511,957.50.

Tempus AI Stock Performance

TEM opened at $35.54 on Friday. The firm’s 50-day moving average is $51.70. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49.

Analysts Set New Price Targets

Several research analysts have issued reports on TEM shares. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Piper Sandler reissued a “neutral” rating and issued a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Loop Capital increased their target price on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Wolfe Research began coverage on Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target for the company. Finally, Guggenheim started coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $56.00.

Check Out Our Latest Stock Analysis on TEM

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. EFG Asset Management North America Corp. acquired a new position in shares of Tempus AI in the second quarter valued at about $1,333,000. ARK Investment Management LLC purchased a new position in Tempus AI during the 2nd quarter worth approximately $18,294,000. Northwestern University acquired a new stake in shares of Tempus AI in the second quarter worth $491,000. Alphabet Inc. purchased a new position in shares of Tempus AI during the second quarter worth $54,289,000. Finally, Pier Capital LLC purchased a new position in shares of Tempus AI during the second quarter worth $2,301,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read More